313 related articles for article (PubMed ID: 37006260)
41. Adipose-Derived Mesenchymal Stem Cells Reprogram M1 Macrophage Metabolism
Yuan Y; Ni S; Zhuge A; Li L; Li B
Front Immunol; 2022; 13():859806. PubMed ID: 35757749
[TBL] [Abstract][Full Text] [Related]
42. Changes in Lysophospholipid Components in Ulcerative Colitis and Colitis-associated Cancer.
Sonoda H; Kitamura C; Kano K; Anzai H; Nagai Y; Abe S; Yokoyama Y; Ishii H; Kishikawa J; Murono K; Emoto S; Sasaki K; Kawai K; Nozawa H; Aoki J; Ishihara S
Anticancer Res; 2022 May; 42(5):2461-2468. PubMed ID: 35489747
[TBL] [Abstract][Full Text] [Related]
43. Biomarkers for Early Detection of Colitis-associated Colorectal Cancer - Current Concepts, Future Trends.
Mackiewicz T; Sowa A; Fichna J
Curr Drug Targets; 2021; 22(1):137-145. PubMed ID: 32077822
[TBL] [Abstract][Full Text] [Related]
44. Heme protects intestinal mucosal barrier in DSS-induced colitis through regulating macrophage polarization in both HO-1-dependent and HO-1-independent way.
Wu Y; Wu B; Zhang Z; Lu H; Fan C; Qi Q; Gao Y; Li H; Feng C; Zuo J; Tang W
FASEB J; 2020 Jun; 34(6):8028-8043. PubMed ID: 32301543
[TBL] [Abstract][Full Text] [Related]
45. Ginsenoside Rg1 ameliorated experimental colitis by regulating the balance of M1/M2 macrophage polarization and the homeostasis of intestinal flora.
Long J; Liu XK; Kang ZP; Wang MX; Zhao HM; Huang JQ; Xiao QP; Liu DY; Zhong YB
Eur J Pharmacol; 2022 Feb; 917():174742. PubMed ID: 34999087
[TBL] [Abstract][Full Text] [Related]
46. The role of FKBP51 in the prognosis of ulcerative colitis-associated colorectal cancer.
Xia Z; Zhang G; Wang C; Feng Y
Adv Med Sci; 2021 Mar; 66(1):89-97. PubMed ID: 33461100
[TBL] [Abstract][Full Text] [Related]
47. Expression of CA2 and CA9 carbonic anhydrases in ulcerative colitis and ulcerative colitis-associated colorectal cancer.
Nakada N; Mikami T; Horie K; Nagashio R; Sakurai Y; Sanoyama I; Yoshida T; Sada M; Kobayashi K; Sato Y; Okayasu I; Murakumo Y
Pathol Int; 2020 Aug; 70(8):523-532. PubMed ID: 32410301
[TBL] [Abstract][Full Text] [Related]
48. Comprehensive Integrative Analysis Reveals the Association of
Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
[TBL] [Abstract][Full Text] [Related]
49. Targeted Sequencing of Cytokine-Induced PI3K-Related Genes in Ulcerative Colitis, Colorectal Cancer and Colitis-Associated Cancer.
Razali NN; Raja Ali RA; Muhammad Nawawi KN; Yahaya A; Mokhtar NM
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232773
[TBL] [Abstract][Full Text] [Related]
50. Bacteroides fragilis restricts colitis-associated cancer via negative regulation of the NLRP3 axis.
Shao X; Sun S; Zhou Y; Wang H; Yu Y; Hu T; Yao Y; Zhou C
Cancer Lett; 2021 Dec; 523():170-181. PubMed ID: 34627951
[TBL] [Abstract][Full Text] [Related]
51. A potential therapeutic approach for ulcerative colitis: targeted regulation of macrophage polarization through phytochemicals.
Wang K; Mao T; Lu X; Wang M; Yun Y; Jia Z; Shi L; Jiang H; Li J; Shi R
Front Immunol; 2023; 14():1155077. PubMed ID: 37197668
[TBL] [Abstract][Full Text] [Related]
52. Pou3f1 mediates the effect of Nfatc3 on ulcerative colitis-associated colorectal cancer by regulating inflammation.
Lin Y; Wang D; Zhao H; Li D; Li X; Lin L
Cell Mol Biol Lett; 2022 Sep; 27(1):75. PubMed ID: 36064319
[TBL] [Abstract][Full Text] [Related]
53. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines.
Wang ZL; Wang YD; Wang K; Li JA; Li L
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4941-4948. PubMed ID: 30070340
[TBL] [Abstract][Full Text] [Related]
54. MUC1-mediated Macrophage Activation Promotes Colitis-associated Colorectal Cancer via Activating the Interleukin-6/ Signal Transducer and Activator of Transcription 3 Axis.
Sheng YH; Davies JM; Wang R; Wong KY; Giri R; Yang Y; Begun J; Florin TH; Hasnain SZ; McGuckin MA
Cell Mol Gastroenterol Hepatol; 2022; 14(4):789-811. PubMed ID: 35809803
[TBL] [Abstract][Full Text] [Related]
55. MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response.
Essandoh K; Li Y; Huo J; Fan GC
Shock; 2016 Aug; 46(2):122-31. PubMed ID: 26954942
[TBL] [Abstract][Full Text] [Related]
56. Fenretinide regulates macrophage polarization to protect against experimental colitis induced by dextran sulfate sodium.
Cao Y; Lin Y; Sun Y; Liu W; Shao Y; Zheng C
Bioengineered; 2021 Dec; 12(1):151-161. PubMed ID: 33380244
[TBL] [Abstract][Full Text] [Related]
57. Chemerin aggravates DSS-induced colitis by suppressing M2 macrophage polarization.
Lin Y; Yang X; Yue W; Xu X; Li B; Zou L; He R
Cell Mol Immunol; 2014 Jul; 11(4):355-66. PubMed ID: 24727542
[TBL] [Abstract][Full Text] [Related]
58. Macrophage-based nanotherapeutic strategies in ulcerative colitis.
Zhang J; Zhao Y; Hou T; Zeng H; Kalambhe D; Wang B; Shen X; Huang Y
J Control Release; 2020 Apr; 320():363-380. PubMed ID: 32001299
[TBL] [Abstract][Full Text] [Related]
59. A novel ceRNA-immunoregulatory axis based on immune cell infiltration in ulcerative colitis-associated colorectal carcinoma by integrated weighted gene co-expression network analysis.
Yin S; Li X; Xiong Z; Xie M; Jin L; Chen H; Mao C; Zhang F; Lian L
BMC Gastroenterol; 2022 Apr; 22(1):188. PubMed ID: 35428188
[TBL] [Abstract][Full Text] [Related]
60. Extracellular vesicles derived from bone marrow mesenchymal stem cells attenuate dextran sodium sulfate-induced ulcerative colitis by promoting M2 macrophage polarization.
Cao L; Xu H; Wang G; Liu M; Tian D; Yuan Z
Int Immunopharmacol; 2019 Jul; 72():264-274. PubMed ID: 31005036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
